A Randomized Controlled Trial Comparing Two Timing Regimens of Pico-salax for Colon Cleansing Prior to Colonoscopy
Launched by QUEEN'S UNIVERSITY · Apr 20, 2009
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • colonoscopy indicated
- Exclusion Criteria:
- • congestive heart failure
- • ascites
- • renal failure
- • hyponatremia
- • previous intestinal surgery
About Queen's University
Queen's University is a distinguished research institution located in Kingston, Ontario, Canada, known for its commitment to advancing knowledge and innovation in the health sciences. As a clinical trial sponsor, Queen's University fosters a collaborative environment that bridges academic research and clinical practice, aiming to enhance patient care and outcomes through rigorous scientific investigation. The university actively engages in a wide range of clinical studies, leveraging its expertise in diverse therapeutic areas to contribute to the development of new treatments and interventions. With a focus on ethical standards and regulatory compliance, Queen's University is dedicated to ensuring the integrity and reliability of its clinical research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kingston, Ontario, Canada
Patients applied
Trial Officials
Lawrence Hookey, MD
Principal Investigator
Queen's University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials